ARTAN Bio
PrivateLast Round
Seed
Jun 4, 2026
Total Funding Raised
$200,000
Company Overview
ARTAN Bio is a biotechnology company developing a novel engineered suppressor tRNA system to address genetic and age-related diseases caused by nonsense mutations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, DAOs, Tokenization
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ARTAN Bio Comps
Public and private peers based on sector, stage, and business model.
ARTAN Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 4, 2026 |
ARTAN Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| VitaDAO | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 4, 2026
$200K round with participation from VitaDAO.
ARTAN Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ARTAN Bio's valuation, stock price, and market status.
